Sanofi, GSK get Indian approval for trial of COVID-19 vaccine
Sanofi and GlaxoSmithKline have received an approval from Indian authorities for a late-stage clinical trial… Read More
3 years ago
Sanofi
Sanofi’s confidence in its COVID-19 vaccine candidates has increased this summer
The company is working on two of the more than 150 potential vaccines being developed… Read More
4 years ago
Britain nears US$625 million Sanofi/GSK COVID-19 vaccine deal: report
Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and… Read More
4 years ago
Top pharma eyes approval of COVID-19 vaccine by first half of 2021
There are currently no vaccines to prevent the coronavirus that has infected more than 9… Read More
4 years ago
Pharma firm investigated over epilepsy drug linked to birth defects
Sanofi said on Tuesday it was being investigated over Depakine, an epilepsy drug which caused… Read More
5 years ago
Drugmakers hike prices on over 200 drugs
Drugmakers including Pfizer, GlaxoSmithKline (GSK) and Sanofi are planning to hike U.S. list prices on… Read More
5 years ago
No carcinogen found in alternatives of Zantac: US FDA
The US Food and Drug Administration said on Wednesday that alternatives to popular heartburn drug… Read More
5 years ago
Philippines to charge drugmaker, govt over dengue deaths
The Philippine Department of Justice found probable cause to indict officials from a drugmaker and… Read More
6 years ago
Our pills don’t cause racism, drugmaker Sanofi tells Roseanne
Pulled off air over a racist tweet, US sitcom star Roseanne Barr has blamed her… Read More
7 years ago
Sanofi digs deep to buy US haemophilia group Bioverativ for $11.6 billion
PARIS: French healthcare group Sanofi has agreed to buy US haemophilia specialist Bioverativ for $11.6… Read More
7 years ago
Dengue vaccine not deadly, says maker
MANILA: A world-first dengue vaccination programme in the Philippines that was suspended over safety concerns… Read More
7 years ago